| 0 |
MAZZOTTI REACTION |
2 |
0.1818 |
| 1 |
SCHISTOSOMIASIS |
11 |
0.1429 |
| 2 |
CEREBRAL PARENCHYMAL CALCIFICATION |
1 |
0.1429 |
| 3 |
PARASITIC ENCEPHALITIS |
1 |
0.1111 |
| 4 |
HYMENOLEPIASIS |
1 |
0.1111 |
| 5 |
SUBCONJUNCTIVAL FIBROSIS |
1 |
0.0909 |
| 6 |
ANGIOGRAM PERIPHERAL ABNORMAL |
1 |
0.0769 |
| 7 |
TAENIASIS |
3 |
0.0714 |
| 8 |
NEUROCYSTICERCOSIS |
3 |
0.0667 |
| 9 |
HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS |
1 |
0.0588 |
| 10 |
NECK CRUSHING |
1 |
0.0500 |
| 11 |
HEPATITIS B DNA ASSAY POSITIVE |
5 |
0.0391 |
| 12 |
PROGRESSIVE MUSCULAR ATROPHY |
1 |
0.0323 |
| 13 |
PORTAL VEIN CAVERNOUS TRANSFORMATION |
1 |
0.0244 |
| 14 |
TONGUE ATROPHY |
1 |
0.0204 |
| 15 |
ARTERIAL STENOSIS LIMB |
1 |
0.0196 |
| 16 |
PLAGUE |
1 |
0.0149 |
| 17 |
RED BLOOD CELL SCHISTOCYTES PRESENT |
4 |
0.0123 |
| 18 |
SALMONELLA TEST POSITIVE |
1 |
0.0116 |
| 19 |
CEREBRAL MASS EFFECT |
4 |
0.0110 |
| 20 |
THERAPEUTIC RESPONSE PROLONGED |
1 |
0.0106 |
| 21 |
ECZEMA INFANTILE |
1 |
0.0104 |
| 22 |
MULTIPLE DRUG HYPERSENSITIVITY |
1 |
0.0104 |
| 23 |
VULVA CYST |
1 |
0.0095 |
| 24 |
PORTAL FIBROSIS |
2 |
0.0093 |
| 25 |
EXTRAOCULAR MUSCLE DISORDER |
3 |
0.0093 |
| 26 |
CNS VENTRICULITIS |
3 |
0.0092 |
| 27 |
HABITUAL ABORTION |
1 |
0.0088 |
| 28 |
GASTRIC PH INCREASED |
1 |
0.0087 |
| 29 |
EYELASH THICKENING |
1 |
0.0083 |
| 30 |
PLASMODIUM FALCIPARUM INFECTION |
1 |
0.0081 |
| 31 |
SPLINTER HAEMORRHAGES |
1 |
0.0073 |
| 32 |
VASCULITIS CEREBRAL |
3 |
0.0067 |
| 33 |
BILIARY FISTULA |
1 |
0.0065 |
| 34 |
CERVIX CANCER METASTATIC |
1 |
0.0061 |
| 35 |
CYST RUPTURE |
4 |
0.0059 |
| 36 |
VESSEL PUNCTURE SITE HAEMATOMA |
1 |
0.0051 |
| 37 |
BIRTH MARK |
1 |
0.0048 |
| 38 |
PARALYSIS FLACCID |
1 |
0.0046 |
| 39 |
OPTIC DISC HAEMORRHAGE |
1 |
0.0044 |
| 40 |
HELMINTHIC INFECTION |
1 |
0.0041 |
| 41 |
SUPERFICIAL VEIN PROMINENCE |
1 |
0.0039 |
| 42 |
SYMBLEPHARON |
1 |
0.0038 |
| 43 |
SPINAL MUSCULAR ATROPHY |
1 |
0.0037 |
| 44 |
SUDDEN VISUAL LOSS |
1 |
0.0036 |
| 45 |
SHUNT MALFUNCTION |
1 |
0.0035 |
| 46 |
EYE INFECTION STAPHYLOCOCCAL |
1 |
0.0035 |
| 47 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
4 |
0.0032 |
| 48 |
CEREBRAL CYST |
2 |
0.0029 |
| 49 |
PTERYGIUM |
1 |
0.0029 |
| 50 |
ORAL DISCHARGE |
1 |
0.0027 |
| 51 |
LIPID METABOLISM DISORDER |
1 |
0.0026 |
| 52 |
ARACHNOID CYST |
1 |
0.0025 |
| 53 |
POLYSEROSITIS |
1 |
0.0023 |
| 54 |
DIVORCED |
1 |
0.0023 |
| 55 |
HOMELESS |
1 |
0.0022 |
| 56 |
VEIN DISCOLOURATION |
1 |
0.0021 |
| 57 |
STEROID DIABETES |
3 |
0.0020 |
| 58 |
CRYPTOSPORIDIOSIS INFECTION |
1 |
0.0019 |
| 59 |
HYPEREOSINOPHILIC SYNDROME |
1 |
0.0018 |
| 60 |
NAIL BED BLEEDING |
1 |
0.0018 |
| 61 |
INTENTION TREMOR |
1 |
0.0018 |
| 62 |
CONJUNCTIVAL HYPERAEMIA |
6 |
0.0017 |
| 63 |
SINOATRIAL BLOCK |
1 |
0.0017 |
| 64 |
GRUNTING |
1 |
0.0017 |
| 65 |
UNINTENTIONAL USE FOR UNAPPROVED INDICATION |
1 |
0.0017 |
| 66 |
PERIORAL DERMATITIS |
1 |
0.0016 |
| 67 |
INCREASED VISCOSITY OF BRONCHIAL SECRETION |
1 |
0.0016 |
| 68 |
HYPERCHLORAEMIA |
1 |
0.0016 |
| 69 |
RESTING TREMOR |
1 |
0.0015 |
| 70 |
SPUTUM PURULENT |
1 |
0.0015 |
| 71 |
PERSONAL RELATIONSHIP ISSUE |
1 |
0.0015 |
| 72 |
JARISCH-HERXHEIMER REACTION |
1 |
0.0014 |
| 73 |
PALMOPLANTAR KERATODERMA |
1 |
0.0014 |
| 74 |
TRAUMATIC FRACTURE |
1 |
0.0014 |
| 75 |
LIMB CRUSHING INJURY |
1 |
0.0013 |
| 76 |
ANOSOGNOSIA |
1 |
0.0013 |
| 77 |
HYDROCEPHALUS |
7 |
0.0013 |
| 78 |
MYOPERICARDITIS |
1 |
0.0013 |
| 79 |
INFECTION PARASITIC |
1 |
0.0013 |
| 80 |
GALLBLADDER POLYP |
1 |
0.0013 |
| 81 |
SUPERINFECTION BACTERIAL |
1 |
0.0013 |
| 82 |
STRONGYLOIDIASIS |
2 |
0.0012 |
| 83 |
COMPULSIVE SEXUAL BEHAVIOUR |
1 |
0.0012 |
| 84 |
HEPATORENAL SYNDROME |
2 |
0.0012 |
| 85 |
VITREOUS OPACITIES |
1 |
0.0012 |
| 86 |
LIP PRURITUS |
1 |
0.0012 |
| 87 |
FOOD INTERACTION |
2 |
0.0011 |
| 88 |
EXTENSOR PLANTAR RESPONSE |
1 |
0.0011 |
| 89 |
RETINAL EXUDATES |
1 |
0.0011 |
| 90 |
ANTISOCIAL BEHAVIOUR |
1 |
0.0010 |
| 91 |
PORTAL HYPERTENSION |
3 |
0.0010 |
| 92 |
RETINAL TOXICITY |
1 |
0.0010 |
| 93 |
NASAL INFLAMMATION |
1 |
0.0009 |
| 94 |
OESOPHAGEAL VARICES HAEMORRHAGE |
2 |
0.0009 |
| 95 |
COMPLEX PARTIAL SEIZURES |
1 |
0.0009 |
| 96 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
2 |
0.0009 |
| 97 |
APPLICATION SITE DISCHARGE |
1 |
0.0009 |
| 98 |
NEUROLOGICAL DECOMPENSATION |
2 |
0.0009 |
| 99 |
PENILE SWELLING |
1 |
0.0008 |
| 100 |
NOCTURNAL DYSPNOEA |
1 |
0.0008 |
| 101 |
FEELING GUILTY |
1 |
0.0008 |
| 102 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
2 |
0.0008 |
| 103 |
ANGIONEUROTIC OEDEMA |
2 |
0.0007 |
| 104 |
EOSINOPHILIA |
13 |
0.0007 |
| 105 |
URETERIC OBSTRUCTION |
1 |
0.0007 |
| 106 |
EFFUSION |
1 |
0.0007 |
| 107 |
MENINGITIS BACTERIAL |
1 |
0.0007 |
| 108 |
ACNE CYSTIC |
2 |
0.0007 |
| 109 |
CUSHINGOID |
2 |
0.0006 |
| 110 |
PORTAL VEIN THROMBOSIS |
2 |
0.0006 |
| 111 |
OPTIC ATROPHY |
1 |
0.0006 |
| 112 |
SEBORRHOEIC DERMATITIS |
1 |
0.0006 |
| 113 |
ARTHROPOD STING |
1 |
0.0006 |
| 114 |
TONGUE COATED |
1 |
0.0006 |
| 115 |
PRODUCT PRESCRIBING ISSUE |
12 |
0.0006 |
| 116 |
RETINOPATHY |
2 |
0.0005 |
| 117 |
HUMAN HERPESVIRUS 6 INFECTION |
1 |
0.0005 |
| 118 |
CLEFT PALATE |
1 |
0.0005 |
| 119 |
CONVERSION DISORDER |
1 |
0.0005 |
| 120 |
PERIPHERAL ISCHAEMIA |
2 |
0.0005 |
| 121 |
LIVEDO RETICULARIS |
1 |
0.0005 |
| 122 |
LATENT TUBERCULOSIS |
1 |
0.0005 |
| 123 |
AMYOTROPHIC LATERAL SCLEROSIS |
1 |
0.0005 |
| 124 |
OCULAR ICTERUS |
2 |
0.0005 |
| 125 |
LARGE INTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 126 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
0.0004 |
| 127 |
HAEMOLYTIC URAEMIC SYNDROME |
1 |
0.0004 |
| 128 |
HYPERTRANSAMINASAEMIA |
3 |
0.0004 |
| 129 |
EYELID OEDEMA |
5 |
0.0004 |
| 130 |
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE |
1 |
0.0004 |
| 131 |
ABDOMINAL TENDERNESS |
2 |
0.0004 |
| 132 |
HYPERNATRAEMIA |
2 |
0.0004 |
| 133 |
VASODILATATION |
1 |
0.0004 |
| 134 |
URINARY TRACT INFECTION BACTERIAL |
1 |
0.0004 |
| 135 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
2 |
0.0004 |
| 136 |
HEPATOSPLENOMEGALY |
1 |
0.0004 |
| 137 |
RETINAL DISORDER |
1 |
0.0004 |
| 138 |
HEPATITIS TOXIC |
1 |
0.0004 |
| 139 |
ALCOHOL ABUSE |
1 |
0.0004 |
| 140 |
GAMBLING DISORDER |
1 |
0.0004 |
| 141 |
SKIN WRINKLING |
1 |
0.0004 |
| 142 |
TYPE IV HYPERSENSITIVITY REACTION |
1 |
0.0004 |
| 143 |
EOSINOPHIL COUNT INCREASED |
3 |
0.0004 |
| 144 |
PHARYNGEAL DISORDER |
1 |
0.0003 |
| 145 |
PARAPLEGIA |
1 |
0.0003 |
| 146 |
HEPATITIS FULMINANT |
1 |
0.0003 |
| 147 |
CREPITATIONS |
1 |
0.0003 |
| 148 |
CHOLECYSTITIS |
4 |
0.0003 |
| 149 |
MIXED LIVER INJURY |
1 |
0.0003 |
| 150 |
LOSS OF EMPLOYMENT |
1 |
0.0003 |
| 151 |
VARICES OESOPHAGEAL |
1 |
0.0003 |
| 152 |
PATHOGEN RESISTANCE |
3 |
0.0003 |
| 153 |
DERMATITIS ACNEIFORM |
2 |
0.0003 |
| 154 |
PENILE PAIN |
1 |
0.0003 |
| 155 |
DUODENITIS |
1 |
0.0003 |
| 156 |
CYST |
4 |
0.0003 |
| 157 |
SWOLLEN JOINT COUNT INCREASED |
1 |
0.0003 |
| 158 |
CYTOLYTIC HEPATITIS |
1 |
0.0003 |
| 159 |
LYME DISEASE |
1 |
0.0003 |
| 160 |
HEPATIC CYST |
1 |
0.0003 |
| 161 |
TACHYPHRENIA |
1 |
0.0003 |
| 162 |
HYPERREFLEXIA |
1 |
0.0003 |
| 163 |
FOLLICULITIS |
3 |
0.0003 |
| 164 |
MUSCLE CONTRACTIONS INVOLUNTARY |
1 |
0.0003 |
| 165 |
OSTEONECROSIS |
9 |
0.0003 |
| 166 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 167 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
2 |
0.0003 |
| 168 |
POLYDIPSIA |
1 |
0.0003 |
| 169 |
RHINITIS |
2 |
0.0002 |
| 170 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 171 |
HOMICIDAL IDEATION |
1 |
0.0002 |
| 172 |
SHOCK HAEMORRHAGIC |
2 |
0.0002 |
| 173 |
ABNORMAL FAECES |
2 |
0.0002 |
| 174 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 175 |
BRAIN OEDEMA |
3 |
0.0002 |
| 176 |
HEPATIC CYTOLYSIS |
3 |
0.0002 |
| 177 |
DRUG EXPOSURE DURING PREGNANCY |
8 |
0.0002 |
| 178 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 179 |
HEPATITIS |
6 |
0.0002 |
| 180 |
MELANOCYTIC NAEVUS |
1 |
0.0002 |
| 181 |
RHEUMATIC FEVER |
1 |
0.0002 |
| 182 |
PAPILLOEDEMA |
1 |
0.0002 |
| 183 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 184 |
ACUTE HEPATIC FAILURE |
3 |
0.0002 |
| 185 |
HEPATOCELLULAR INJURY |
3 |
0.0002 |
| 186 |
FAECAL INCONTINENCE |
1 |
0.0002 |
| 187 |
STILLBIRTH |
1 |
0.0002 |
| 188 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 189 |
VULVOVAGINAL PRURITUS |
1 |
0.0002 |
| 190 |
NEUTROPHIL COUNT INCREASED |
2 |
0.0002 |
| 191 |
VARICOSE VEIN |
1 |
0.0002 |
| 192 |
FOETAL DEATH |
1 |
0.0002 |
| 193 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 194 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 195 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 196 |
ABSCESS |
3 |
0.0002 |
| 197 |
MALNUTRITION |
2 |
0.0002 |
| 198 |
MACULAR OEDEMA |
1 |
0.0002 |
| 199 |
REBOUND EFFECT |
2 |
0.0002 |
| 200 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 201 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 202 |
VISUAL DISTURBANCE |
1 |
0.0002 |
| 203 |
RHEUMATOID FACTOR POSITIVE |
1 |
0.0002 |
| 204 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 205 |
SPLENOMEGALY |
2 |
0.0002 |
| 206 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 207 |
SYMPTOM RECURRENCE |
1 |
0.0002 |
| 208 |
ENDOPHTHALMITIS |
1 |
0.0002 |
| 209 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 210 |
OLIGURIA |
1 |
0.0002 |
| 211 |
CHOLESTASIS |
3 |
0.0002 |
| 212 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
4 |
0.0002 |
| 213 |
INCOHERENT |
1 |
0.0002 |
| 214 |
HEPATITIS ACUTE |
1 |
0.0002 |
| 215 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
| 216 |
HYPOKALAEMIA |
7 |
0.0002 |
| 217 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 218 |
FORMICATION |
1 |
0.0001 |
| 219 |
PANCYTOPENIA |
8 |
0.0001 |
| 220 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 221 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
1 |
0.0001 |
| 222 |
RASH PUSTULAR |
1 |
0.0001 |
| 223 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 224 |
ARTHROPOD BITE |
1 |
0.0001 |
| 225 |
HEPATOTOXICITY |
3 |
0.0001 |
| 226 |
DUODENAL ULCER PERFORATION |
1 |
0.0001 |
| 227 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 228 |
DRUG-INDUCED LIVER INJURY |
4 |
0.0001 |
| 229 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 230 |
OBSESSIVE-COMPULSIVE DISORDER |
1 |
0.0001 |
| 231 |
SENSORY LOSS |
1 |
0.0001 |
| 232 |
HYPERAESTHESIA |
1 |
0.0001 |
| 233 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 234 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 235 |
LIVE BIRTH |
1 |
0.0001 |
| 236 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 237 |
UNRESPONSIVE TO STIMULI |
3 |
0.0001 |
| 238 |
MYOPATHY |
1 |
0.0001 |
| 239 |
LIVER DISORDER |
5 |
0.0001 |
| 240 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 241 |
SEIZURE |
13 |
0.0001 |
| 242 |
MYELOSUPPRESSION |
4 |
0.0001 |
| 243 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 244 |
OPTIC NEURITIS |
1 |
0.0001 |
| 245 |
UROSEPSIS |
1 |
0.0001 |
| 246 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 247 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 248 |
HEPATOMEGALY |
1 |
0.0001 |
| 249 |
HYPOTONIA |
1 |
0.0001 |
| 250 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 251 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 252 |
HELICOBACTER INFECTION |
1 |
0.0001 |
| 253 |
FAECES DISCOLOURED |
2 |
0.0001 |
| 254 |
ANGIOEDEMA |
4 |
0.0001 |
| 255 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 256 |
PRODUCT USE IN UNAPPROVED INDICATION |
22 |
0.0001 |
| 257 |
CHROMATURIA |
2 |
0.0001 |
| 258 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 259 |
SCAB |
1 |
0.0001 |
| 260 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 261 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 262 |
DISEASE RECURRENCE |
4 |
0.0001 |
| 263 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 264 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 265 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 266 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 267 |
PEMPHIGUS |
1 |
0.0001 |
| 268 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 269 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 270 |
RASH GENERALISED |
2 |
0.0001 |
| 271 |
HAND DEFORMITY |
1 |
0.0001 |
| 272 |
BEDRIDDEN |
1 |
0.0001 |
| 273 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 274 |
BLOOD BILIRUBIN INCREASED |
2 |
0.0001 |
| 275 |
OEDEMA |
4 |
0.0001 |
| 276 |
PNEUMONITIS |
2 |
0.0001 |
| 277 |
SKIN LESION |
2 |
0.0001 |
| 278 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 279 |
TREATMENT FAILURE |
6 |
0.0001 |
| 280 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 281 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 282 |
APHONIA |
1 |
0.0001 |
| 283 |
EYE PAIN |
4 |
0.0001 |
| 284 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 285 |
BRONCHOSPASM |
1 |
0.0001 |
| 286 |
ANGINA PECTORIS |
2 |
0.0001 |
| 287 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
2 |
0.0001 |
| 288 |
ASCITES |
2 |
0.0001 |
| 289 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 290 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 291 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 292 |
CYANOSIS |
1 |
0.0001 |
| 293 |
PYREXIA |
22 |
0.0001 |
| 294 |
ARRHYTHMIA |
3 |
0.0001 |
| 295 |
SCIATICA |
1 |
0.0001 |
| 296 |
MANIA |
1 |
0.0001 |
| 297 |
GENERAL PHYSICAL HEALTH DETERIORATION |
7 |
0.0001 |
| 298 |
LEUKOPENIA |
3 |
0.0001 |
| 299 |
SKIN DISORDER |
2 |
0.0001 |
| 300 |
URTICARIA |
10 |
0.0001 |
| 301 |
PERICARDITIS |
1 |
0.0001 |
| 302 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 303 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 304 |
SCAR |
1 |
0.0001 |
| 305 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 306 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 307 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 308 |
DRUG ERUPTION |
1 |
0.0001 |
| 309 |
THIRST |
1 |
0.0001 |
| 310 |
SYNOVITIS |
1 |
0.0001 |
| 311 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 312 |
TREATMENT NONCOMPLIANCE |
3 |
0.0001 |
| 313 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 314 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 315 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 316 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 317 |
CONDITION AGGRAVATED |
16 |
0.0001 |
| 318 |
ACUTE KIDNEY INJURY |
8 |
0.0001 |
| 319 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 320 |
SKIN FISSURES |
1 |
0.0001 |
| 321 |
DISORIENTATION |
2 |
0.0001 |
| 322 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 323 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 324 |
PERITONITIS |
1 |
0.0000 |
| 325 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 326 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 327 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 328 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 329 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 330 |
GLOSSODYNIA |
1 |
0.0000 |
| 331 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 332 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 333 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 334 |
LOCALISED INFECTION |
1 |
0.0000 |
| 335 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 336 |
FIBROMYALGIA |
1 |
0.0000 |
| 337 |
UNDERDOSE |
3 |
0.0000 |
| 338 |
LIVER INJURY |
1 |
0.0000 |
| 339 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 340 |
OFF LABEL USE |
35 |
0.0000 |
| 341 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 342 |
HAEMATEMESIS |
1 |
0.0000 |
| 343 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 344 |
ABDOMINAL PAIN |
9 |
0.0000 |
| 345 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 346 |
SEDATION |
1 |
0.0000 |
| 347 |
SPEECH DISORDER |
2 |
0.0000 |
| 348 |
ANHEDONIA |
1 |
0.0000 |
| 349 |
PANCREATITIS |
2 |
0.0000 |
| 350 |
DRUG INTERACTION |
6 |
0.0000 |
| 351 |
JAUNDICE |
1 |
0.0000 |
| 352 |
NEUTROPENIA |
5 |
0.0000 |
| 353 |
PALLOR |
1 |
0.0000 |
| 354 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 355 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 356 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 357 |
SEPSIS |
4 |
0.0000 |
| 358 |
HAEMOPTYSIS |
1 |
0.0000 |
| 359 |
WOUND |
1 |
0.0000 |
| 360 |
SKIN EXFOLIATION |
3 |
0.0000 |
| 361 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 362 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 363 |
ABDOMINAL PAIN UPPER |
7 |
0.0000 |
| 364 |
WHEEZING |
2 |
0.0000 |
| 365 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 366 |
PREMATURE BABY |
1 |
0.0000 |
| 367 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 368 |
SUICIDE ATTEMPT |
2 |
0.0000 |
| 369 |
OEDEMA PERIPHERAL |
4 |
0.0000 |
| 370 |
HYPERSENSITIVITY |
6 |
0.0000 |
| 371 |
VOMITING |
15 |
0.0000 |
| 372 |
DRUG INEFFECTIVE |
41 |
0.0000 |
| 373 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 374 |
HYPERHIDROSIS |
4 |
0.0000 |
| 375 |
NIGHT SWEATS |
1 |
0.0000 |
| 376 |
EYE DISORDER |
1 |
0.0000 |
| 377 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 378 |
URINARY RETENTION |
1 |
0.0000 |
| 379 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 380 |
MYALGIA |
5 |
0.0000 |
| 381 |
DELIRIUM |
1 |
0.0000 |
| 382 |
INJURY |
2 |
0.0000 |
| 383 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 384 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 385 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 386 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 387 |
CRYING |
1 |
0.0000 |
| 388 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 389 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 390 |
RESTLESSNESS |
1 |
0.0000 |
| 391 |
DYSURIA |
1 |
0.0000 |
| 392 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 393 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 394 |
DYSARTHRIA |
1 |
0.0000 |
| 395 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 396 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 397 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 398 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 399 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 400 |
COUGH |
7 |
0.0000 |
| 401 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 402 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 403 |
DYSKINESIA |
1 |
0.0000 |
| 404 |
BLINDNESS |
1 |
0.0000 |
| 405 |
OSTEOPOROSIS |
1 |
0.0000 |
| 406 |
DIZZINESS |
12 |
0.0000 |
| 407 |
POLLAKIURIA |
1 |
0.0000 |
| 408 |
HEADACHE |
15 |
0.0000 |
| 409 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 410 |
MENTAL DISORDER |
1 |
0.0000 |
| 411 |
DEHYDRATION |
3 |
0.0000 |
| 412 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 413 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 414 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 415 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 416 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 417 |
NO ADVERSE EVENT |
4 |
0.0000 |
| 418 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 419 |
ADVERSE EVENT |
2 |
0.0000 |
| 420 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 421 |
RENAL DISORDER |
1 |
0.0000 |
| 422 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 423 |
SWELLING |
2 |
0.0000 |
| 424 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 425 |
HYPOAESTHESIA |
3 |
0.0000 |
| 426 |
SYNCOPE |
2 |
0.0000 |
| 427 |
THERAPY CESSATION |
1 |
0.0000 |
| 428 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 429 |
BRADYCARDIA |
1 |
0.0000 |
| 430 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 431 |
INSOMNIA |
5 |
0.0000 |
| 432 |
ASTHENIA |
7 |
0.0000 |
| 433 |
OVERDOSE |
4 |
0.0000 |
| 434 |
MALAISE |
8 |
0.0000 |
| 435 |
PRURITUS |
7 |
0.0000 |
| 436 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 437 |
ARTHROPATHY |
1 |
0.0000 |
| 438 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 439 |
BLISTER |
1 |
0.0000 |
| 440 |
HYPONATRAEMIA |
1 |
0.0000 |
| 441 |
ANXIETY |
5 |
0.0000 |
| 442 |
CONVULSION |
1 |
0.0000 |
| 443 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 444 |
DECREASED APPETITE |
4 |
0.0000 |
| 445 |
DYSPHONIA |
1 |
0.0000 |
| 446 |
PALPITATIONS |
2 |
0.0000 |
| 447 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 448 |
IRRITABILITY |
1 |
0.0000 |
| 449 |
VERTIGO |
1 |
0.0000 |
| 450 |
DISCOMFORT |
1 |
0.0000 |
| 451 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 452 |
CHEST PAIN |
3 |
0.0000 |
| 453 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 454 |
RASH |
7 |
0.0000 |
| 455 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 456 |
ANAEMIA |
3 |
0.0000 |
| 457 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 458 |
AMNESIA |
1 |
0.0000 |
| 459 |
SWELLING FACE |
1 |
0.0000 |
| 460 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 461 |
SOMNOLENCE |
3 |
0.0000 |
| 462 |
BURNING SENSATION |
1 |
0.0000 |
| 463 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 464 |
DIARRHOEA |
9 |
0.0000 |
| 465 |
MOBILITY DECREASED |
1 |
0.0000 |
| 466 |
BRONCHITIS |
1 |
0.0000 |
| 467 |
DIABETES MELLITUS |
1 |
0.0000 |
| 468 |
ARTHRITIS |
1 |
0.0000 |
| 469 |
PARAESTHESIA |
2 |
0.0000 |
| 470 |
PROSTATE CANCER |
1 |
0.0000 |
| 471 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 472 |
DYSPNOEA |
7 |
0.0000 |
| 473 |
DRY MOUTH |
1 |
0.0000 |
| 474 |
TREMOR |
2 |
0.0000 |
| 475 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 476 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 477 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 478 |
NAUSEA |
9 |
0.0000 |
| 479 |
TACHYCARDIA |
1 |
0.0000 |
| 480 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 481 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 482 |
MUSCLE SPASMS |
2 |
0.0000 |
| 483 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 484 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 485 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 486 |
MIGRAINE |
1 |
0.0000 |
| 487 |
CONTUSION |
1 |
0.0000 |
| 488 |
ALOPECIA |
2 |
0.0000 |
| 489 |
HEART RATE INCREASED |
1 |
0.0000 |
| 490 |
HYPOTENSION |
2 |
0.0000 |
| 491 |
SINUSITIS |
1 |
0.0000 |
| 492 |
HYPERTENSION |
2 |
0.0000 |
| 493 |
CONSTIPATION |
2 |
0.0000 |
| 494 |
FATIGUE |
7 |
0.0000 |
| 495 |
WEIGHT INCREASED |
2 |
0.0000 |
| 496 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 497 |
CHILLS |
1 |
0.0000 |
| 498 |
JOINT SWELLING |
1 |
0.0000 |
| 499 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 500 |
PAIN |
5 |
0.0000 |
| 501 |
DEATH |
7 |
0.0000 |
| 502 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 503 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 504 |
DRY SKIN |
1 |
0.0000 |
| 505 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 506 |
VISION BLURRED |
1 |
0.0000 |
| 507 |
WEIGHT DECREASED |
2 |
0.0000 |
| 508 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 509 |
HOSPITALISATION |
1 |
0.0000 |
| 510 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 511 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 512 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 513 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 514 |
ERYTHEMA |
1 |
0.0000 |
| 515 |
ARTHRALGIA |
2 |
0.0000 |
| 516 |
DEPRESSION |
1 |
0.0000 |
| 517 |
FEELING ABNORMAL |
1 |
0.0000 |